AP
About
Ascentage Pharma develops novel small-molecule therapies for cancer, hepatitis B, and age-related diseases. They have developed a pipeline of seven drug candidates that disrupt complex and difficult-to-target protein-protein interactions and are next-generation tyrosine kinase inhibitors.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 118 investors are based in Suzhou, Jiangsu, China.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech
- Location
- Suzhou, China
Contact Information
linkedin.com/in/••••••••
Find more investors like Ascentage
Search Investors